Drug Search Results
More Filters [+]

ARK-E021

Alternative Names: ark-e021, arke021, ark e021
Latest Update: 2013-12-03
Latest Update Note: Clinical Trial Update

Product Description

For mild to moderate acne vulgaris (Sourced from: https://clinicaltrials.gov/ct2/show/NCT01494285)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: M. Arkin 1999
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for ARK-E021

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Acne Vulgaris

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

MA1001

P2

Completed

Acne Vulgaris

2013-10-01

Recent News Events

Date

Type

Title